| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
4
4
2
1
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
A-
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 0.0 | 3.95 | -3.95 |
| Stocks | 93.71 | 0.0 | 93.71 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 0.0 | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 10.24 | 0.0 | 10.24 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 02.28.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 02.28.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Boston Scientific, Inc. | BSX | 30.72 | 8.07 |
| WellPoint Inc | WLP | 19.25 | 6.04 |
| Sohu.com Inc | SOHU | 7.71 | 5.42 |
| Avon Products Inc | AVP | 59.12 | 4.51 |
| Pfizer Inc | PFE | 16.19 | 4.17 |
| Eli Lilly and Company | LLY | 10.97 | 3.65 |
| Yahoo! Inc | YHOO | 22.11 | 3.5 |
| Medtronic, Inc. | MDT | 14.36 | 3.49 |
| Merck & Co Inc | MRK | 12.65 | 2.85 |
| Elizabeth Arden, Inc. | RDEN | -12.71 | 2.69 |
